Telma-MCT 25/12.5 Tablet ER
Marketer
Glenmark Pharmaceuticals Ltd
Salt Composition
Chlorthalidone (12.5mg) + Metoprolol Succinate (25mg) + Telmisartan (40mg)
Overview Telma-MCT 25/12.5 Tablet ER
Micardis Plus 25/12.5 mg Extended-Release tablets combine medications to manage hypertension. This treatment lowers blood pressure by widening blood vessels and improving the heart's pumping action. It also promotes fluid and electrolyte excretion. This medication may be taken with or without food, but consistent timing maximizes effectiveness. Increased urination is a common effect; therefore, daytime administration or at least four hours before sleep is recommended. Dosage and frequency are determined by your physician based on individual needs and response. Continuous use as prescribed is crucial. Side effects such as nausea, diarrhea, indigestion, headache, and lightheadedness may occur. Regular monitoring of kidney function and electrolyte levels is necessary. Optimal results are achieved when combined with lifestyle modifications including balanced nutrition, regular physical activity, and smoking cessation. Increased fluid intake helps counteract potential dryness and thirst. Prior to commencing treatment, inform your doctor of any pregnancy, circulatory issues, liver or kidney disease, and all other medications being taken, as interactions may affect efficacy.
Primary Ingredients of Telma-MCT 25/12.5 Tablet ER
No information provided. Please provide the text you wish me to rewrite.
Uses of Telma-MCT 25/12.5 Tablet ER
Elevated arterial blood pressure
Major Benefits of Telma-MCT 25/12.5 Tablet ER:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Telma-MCT 25/12.5 Extended-Release Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Telma-MCT 25/12.5 Tablet ER:
- Nausea
- Diarrhea
- Upset stomach
- Headache
- Dizziness
- Cold extremities
- Numbness of extremity
- Increased blood lipid level
- Slow heart rate
- Decreased blood pressure
How to use Telma-MCT 25/12.5 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Telma-MCT 25/12.5 Tablet ER whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistent timing is recommended.
How Telma-MCT 25/12.5 Tablet ER works:
Chlorthalidone, a diuretic, facilitates the urinary excretion of excess fluid and select electrolytes. Its long-term effects include vasodilation and enhanced circulation. Metoprolol succinate, a beta-adrenergic blocking agent, acts selectively on the heart to reduce its rate. Conversely, telmisartan, an angiotensin receptor blocker, lowers blood pressure by inhibiting the angiotensin II hormone, resulting in further vasodilation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Telma-MCT 25/12.5 ER tablets with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Extended-release Telma-MCT 25/12.5 tablets are contraindicated in pregnancy due to confirmed fetal risks. In exceptional, life-threatening circumstances, a physician might prescribe them if the potential benefits outweigh the hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Telma-MCT 25/12.5 tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Extended-release Telma-MCT 25/12.5mg tablets can cause drowsiness, visual disturbances, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Exercise caution when prescribing Telma-MCT 25/12.5 ER tablets to individuals with severe renal impairment; dosage modification may be necessary. A physician's consultation is advised. This medication is contraindicated in patients with such conditions.
LiverCAUTION
Individuals with liver impairment should exercise caution when using Telma-MCT 25/12.5 ER tablets; dosage modification may be necessary. A physician's consultation is advised. Telma-MCT 25/12.5 ER tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Telma-MCT 25/12.5 Tablet ER :
Should you forget a dose of your Telma-MCT 25/12.5 ER tablet, take it immediately if you remember. However, near the time for your next dose, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Telma-MCT 25/12.5 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |





